BioTime loses its prime sponsor.

David K. Crossen, an analyst covering BioTime, Inc. (Symbol: BTIM) (Price: $11.75) is no longer employed at NationsBanc Montgomery Securities, Inc. Mr. Crossen wrote at least 19 reports on BioTime. The reports contained numerous material omissions of fact, false statements and factual errors. Since Mr. Crossen’s departure, no analyst at NationsBanc Montgomery has picked up coverage of BioTime.

Short selling involves a risk not associated with the purchase of stock including, but not only limited to, unlimited loss and stock borrowing risks. Additional information is available upon request.